WO2026103833 - PHARMACEUTICAL COMPOSITION OF ARNI AND BISOPROLOL OR SALT THEREOF, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/103833
Publication Date
21.05.2026
International Application No.
PCT/CN2025/134844
International Filing Date
14.11.2025
Title **
[English]
PHARMACEUTICAL COMPOSITION OF ARNI AND BISOPROLOL OR SALT THEREOF, AND USE THEREOF
[French]
COMPOSITION PHARMACEUTIQUE D'ARNI ET DE BISOPROLOL OU D'UN SEL DE CELUI-CI, ET UTILISATION DE CELLE-CI
[Chinese]
一种ARNi与比索洛尔或其盐的药物组合物与应用
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
XING, Wei
SUN, Jingchao
XIAO, Ying
CHEN, Yan
LI, Jinfeng
QIN, Yanhong
Priority Data
202411633111.6
15.11.2024
CN
202510021511.X
06.01.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1631 | |
| EPO | Filing, Examination, Granting | 11606 | |
| Japan | Filing, Examination, Granting | 2018 | |
| South Korea | Filing, Examination, Granting | 1821 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,816
Contact Us
Abstract[English]
Provided in the present invention are a pharmaceutical composition of ARNi and bisoprolol or a salt thereof, and a use thereof. The pharmaceutical composition can be used for diseases such as hypertension and/or heart failure.[French]
La présente invention concerne une composition pharmaceutique d'ARNi et de bisoprolol ou d'un sel de celui-ci, ainsi qu'une utilisation de celle-ci. La composition pharmaceutique peut être utilisée pour des maladies telles que l'hypertension et/ou l'insuffisance cardiaque.[Chinese]
本发明提供了一种ARNi与比索洛尔或其盐的药物组合物与应用，该药物组合物可用于高血压和/或心衰等疾病。